The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction
Open accessAbstract
Importance: Nearly half of all patients with heart failure have preserved ejection fraction (HFpEF) as opposed to reduced ejection fraction (HFrEF), yet associations of biomarkers with future heart failure subtype are incompletely understood. Objective: To evaluate the associations of 12 cardiovascular biomarkers with incident HFpEF vs HFrEF among adults from the general population. Design, Setting, and Participants: This study included 4 longitudinal community-based cohorts: the Cardiovascular Health Study (1989-1990; 1992-1993 for supplemental African-American cohort), the Framingham Heart Study (1995-1998), the Multi-Ethnic Study of Atherosclerosis (2000-2002), and the Prevention of Renal and Vascular End-stage Disease study (1997-1998). Each cohort had prospective ascertainment of incident HFpEF and HFrEF. Data analysis was performed from June 25, 2015, to November 9, 2017. Exposures: The following biomarkers were examined: N-terminal pro B-type natriuretic peptide or brain natriuretic peptide, high-sensitivity troponin T or I, C-reactive protein (CRP), urinary albumin to creatinine ratio (UACR), renin to aldosterone ratio, D-dimer, fibrinogen, soluble suppressor of tumorigenicity, galectin-3, cystatin C, plasminogen activator inhibitor 1, and interleukin 6. Main Outcomes and Measures: Development of incident HFpEF and incident HFrEF. Results: Among the 22 756 participants in these 4 cohorts (12 087 women and 10 669 men; mean [SD] age, 60 [13] years) in the study, during a median follow-up of 12 years, 633 participants developed incident HFpEF, and 841 developed HFrEF. In models adjusted for clinical risk factors of heart failure, 2 biomarkers were significantly associated with incident HFpEF: UACR (hazard ratio [HR], 1.33; 95% CI, 1.20-1.48; P < .001) and natriuretic peptides (HR, 1.27; 95% CI, 1.16-1.40; P < .001), with suggestive associations for high-sensitivity troponin (HR, 1.11; 95% CI, 1.03-1.19; P = .008), plasminogen activator inhibitor 1 (HR, 1.22; 95% CI, 1.03-1.45; P = .02), and fibrinogen (HR, 1.12; 95% CI, 1.03-1.22; P = .01). By contrast, 6 biomarkers were associated with incident HFrEF: natriuretic peptides (HR, 1.54; 95% CI, 1.41-1.68; P < .001), UACR (HR, 1.21; 95% CI, 1.11-1.32; P < .001), high-sensitivity troponin (HR, 1.37; 95% CI, 1.29-1.46; P < .001), cystatin C (HR, 1.19; 95% CI, 1.11-1.27; P < .001), D-dimer (HR, 1.22; 95% CI, 1.11-1.35; P < .001), and CRP (HR, 1.19; 95% CI, 1.11-1.28; P < .001). When directly compared, natriuretic peptides, high-sensitivity troponin, and CRP were more strongly associated with HFrEF compared with HFpEF. Conclusions and Relevance: Biomarkers of renal dysfunction, endothelial dysfunction, and inflammation were associated with incident HFrEF. By contrast, only natriuretic peptides and UACR were associated with HFpEF. These findings highlight the need for future studies focused on identifying novel biomarkers of the risk of HFpEF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290 · cited 2×
“Age, mean (SD), y 73 (6) 59 (10) 62 (10) 49 (12) 60 (13)”
BackgroundMulti-Ethnic Study of Atherosclerosis: Objectives and Design
Bild, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf113 · Cited by 3,942
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564 · cited 2×
“Heart rate, mean (SD), beats/min 68 (11) 64 (10) 63 (10) 69 (10) 66 (11)”
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D'Agostino, R. B., & Steyerberg, E. W. (2011) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,453
Heart Failure: Preventing Disease and Death Worldwide
Ponikowski, P., Anker, S. D., AlHabib, K. F., Cowie, M. R., Force, T. L., Hu, S., Jaarsma, T., Krum, H., Rastogi, V., Rohde, L. E., et al. (2014) · ESC Heart Failure · doi:10.1002/ehf2.12005 · Cited by 1,694
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645
Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study
Lloyd-Jones, D. M., Larson, M. G., Leip, E. P., Beiser, A., D’Agostino, R. B., Kannel, W. B., Murabito, J. M., Vasan, R. S., Benjamin, E. J., & Levy, D. (2002) · Circulation · doi:10.1161/01.cir.0000039105.49749.6f · Cited by 1,613
Self-citationHillege, H. L., Fidler, V., Diercks, G. F. H., van Gilst, W. H., de Zeeuw, D., van Veldhuisen, D. J., Gans, R. O. B., Janssen, W. M. T., Grobbee, D. E., & de Jong, P. E. (2002) · Circulation · doi:10.1161/01.cir.0000031732.78052.81 · Cited by 1,551
Self-citationPhenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction
Shah, S. J., Katz, D. H., Selvaraj, S., Burke, M. A., Yancy, C. W., Gheorghiade, M., Bonow, R. O., Huang, C.-C., & Deo, R. C. (2015) · Circulation · doi:10.1161/circulationaha.114.010637 · Cited by 1,157
Self-citationApplying Cox Regression to Competing Risks
Lunn, M., & McNeil, D. (1995) · Biometrics · doi:10.2307/2532940 · Cited by 975
Kitzman, D. W. (2002) · JAMA · doi:10.1001/jama.288.17.2144 · Cited by 883
Vasan, R. S., Sullivan, L. M., Roubenoff, R., Dinarello, C. A., Harris, T., Benjamin, E. J., Sawyer, D. B., Levy, D., Wilson, P. W. F., & D’Agostino, R. B. (2003) · Circulation · doi:10.1161/01.cir.0000057810.48709.f6 · Cited by 746
Self-citationLedwidge, M., Gallagher, J., Conlon, C., Tallon, E., O’Connell, E., Dawkins, I., Watson, C., O’Hanlon, R., Bermingham, M., Patle, A., et al. (2013) · JAMA · doi:10.1001/jama.2013.7588 · Cited by 664
Brouwers, F. P., de Boer, R. A., van der Harst, P., Voors, A. A., Gansevoort, R. T., Bakker, S. J., Hillege, H. L., van Veldhuisen, D. J., & van Gilst, W. H. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht066 · Cited by 610
Self-citationGalectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
Ho, J. E., Liu, C., Lyass, A., Courchesne, P., Pencina, M. J., Vasan, R. S., Larson, M. G., & Levy, D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.053 · Cited by 589
Self-citationAN APPROACH TO LONGITUDINAL STUDIES IN A COMMUNITY: THE FRAMINGHAM STUDY
Dawber, T. R., Kannel, W. B., & Lyell, L. P. (1963) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1963.tb13299.x · Cited by 560
Bahrami, H., Kronmal, R., Bluemke, D. A., Olson, J., Shea, S., Liu, K., Burke, G. L., & Lima, J. A. C. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.19.2138 · Cited by 552
Self-citationEffects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria
Asselbergs, F. W., Diercks, G. F. H., Hillege, H. L., van Boven, A. J., Janssen, W. M. T., Voors, A. A., de Zeeuw, D., de Jong, P. E., van Veldhuisen, D. J., & van Gilst, W. H. (2004) · Circulation · doi:10.1161/01.cir.0000146378.65439.7a · Cited by 523
Self-citationPrognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study
Wang, T. J., Wollert, K. C., Larson, M. G., Coglianese, E., McCabe, E. L., Cheng, S., Ho, J. E., Fradley, M. G., Ghorbani, A., Xanthakis, V., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.129437 · Cited by 482
Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study
Psaty, B. M., Kuller, L. H., Bild, D., Burke, G. L., Kittner, S. J., Mittelmark, M., Price, T. R., Rautaharju, P. M., & Robbins, J. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(94)00092-8 · Cited by 446
Self-citationHuelsmann, M., Neuhold, S., Resl, M., Strunk, G., Brath, H., Francesconi, C., Adlbrecht, C., Prager, R., Luger, A., Pacher, R., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.069 · Cited by 385 · cited 1×
“Over a mean (SD) follow-up of 12 (3) years, there were a total of 2095 incident HF events.”
BackgroundNovel Metabolic Risk Factors for Incident Heart Failure and Their Relationship With Obesity
Bahrami, H., Bluemke, D. A., Kronmal, R., Bertoni, A. G., Lloyd-Jones, D. M., Shahar, E., Szklo, M., & Lima, J. A. C. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.12.048 · Cited by 367
Self-citationHo, J. E., Enserro, D., Brouwers, F. P., Kizer, J. R., Shah, S. J., Psaty, B. M., Bartz, T. M., Santhanakrishnan, R., Lee, D. S., Chan, C., et al. (2016) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.003116 · Cited by 362
Self-citationSenni, M., Paulus, W. J., Gavazzi, A., Fraser, A. G., Diez, J., Solomon, S. D., Smiseth, O. A., Guazzi, M., Lam, C. S. P., Maggioni, A. P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu204 · Cited by 355
Self-citationPredictors of new-onset heart failure: differences in preserved versus reduced ejection fraction
Ho, J. E., Lyass, A., Lee, D. S., Vasan, R. S., Kannel, W. B., Larson, M. G., & Levy, D. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.972828 · Cited by 343
Self-citationter Maaten, J. M., Damman, K., Verhaar, M. C., Paulus, W. J., Duncker, D. J., Cheng, C., van Heerebeek, L., Hillege, H. L., Lam, C. S. P., Navis, G., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.497 · Cited by 320
Self-citationAgarwal, S. K., Chambless, L. E., Ballantyne, C. M., Astor, B., Bertoni, A. G., Chang, P. P., Folsom, A. R., He, M., Hoogeveen, R. C., Ni, H., et al. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.964841 · Cited by 266
Self-citationResistin, Adiponectin, and Risk of Heart Failure
Frankel, D. S., Vasan, R. S., D'Agostino, R. B., Benjamin, E. J., Levy, D., Wang, T. J., & Meigs, J. B. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.073 · Cited by 255
Self-citationWilleit, P., Kaptoge, S., Welsh, P., Butterworth, A. S., Chowdhury, R., Spackman, S. A., Pennells, L., Gao, P., Burgess, S., Freitag, D. F., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30196-6 · Cited by 223
Self-citationState of the Art: Newer Biomarkers in Heart Failure
de Boer, R. A., Daniels, L. B., Maisel, A. S., & Januzzi, J. L. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.273 · Cited by 188
Self-citationVariability of biomarkers in patients with chronic heart failure and healthy controls
Meijers, W. C., van der Velde, A. R., Muller Kobold, A. C., Dijck-Brouwer, J., Wu, A. H., Jaffe, A., & de Boer, R. A. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.669 · Cited by 146
An Investigation of Coronary Heart Disease in Families: The Framingham Offspring Study
(2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx110 · Cited by 114
Population Risk Prediction Models for Incident Heart Failure: A Systematic Review
Echouffo-Tcheugui, J. B., Greene, S. J., Papadimitriou, L., Zannad, F. M., Yancy, C. W., Gheorghiade, M., & Butler, J. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001896 · Cited by 107
Brouwers, F. P. J., van Gilst, W. H., Damman, K., van den Berg, M. P., Gansevoort, R. T., Bakker, S. J. L., Hillege, H. L., van Veldhuisen, D. J., van der Harst, P., & de Boer, R. A. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001185 · Cited by 95
Self-citationKatz, D. H., Burns, J. A., Aguilar, F. G., Beussink, L., & Shah, S. J. (2014) · JACC: Heart Failure · doi:10.1016/j.jchf.2014.05.016 · Cited by 87
Self-citationKatz, D. H., Selvaraj, S., Aguilar, F. G., Martinez, E. E., Beussink‐Nelson, L., Kim, K. A., Peng, J., Sha, J., Irvin, M. R., Eckfeldt, J. H., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003429 · Cited by 81
Self-citationXanthakis, V., Larson, M. G., Wollert, K. C., Aragam, J. R., Cheng, S. C., Ho, J. E., Coglianese, E. E., Levy, D. A., Colucci, W. S., Felker, G. M., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000399 · Cited by 79
Self-citationValidation of the Health ABC Heart Failure Model for Incident Heart Failure Risk Prediction
Kalogeropoulos, A. P., Psaty, B. M., Vasan, R. S., Georgiopoulou, V. V., Smith, A. L., Smith, N. L., Kritchevsky, S. B., Wilson, P. W. F., Newman, A. B., Harris, T. B., et al. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.904300 · Cited by 77
Self-citationSeliger, S. L., de Lemos, J. A., Neeland, I. J., Christenson, R. H., Gottdiener, J. S., Drazner, M. H., Berry, J. D., Sorkin, J. D., & deFilippi, C. R. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2014.12.018 · Cited by 72
Self-citationSerial galectin-3 and future cardiovascular disease in the general population
van der Velde, A. R., Meijers, W. C., Ho, J. E., Brouwers, F. P. J., Rienstra, M., Bakker, S. J. L., Kobold, A. C. M., van Veldhuisen, D. J., van Gilst, W. H., van der Harst, P., et al. (2016) · Heart · doi:10.1136/heartjnl-2015-308975 · Cited by 59
Self-citationBrouwers, F. P. J., Asselbergs, F. W., Hillege, H. L., de Boer, R. A., Gansevoort, R. T., van Veldhuisen, D. J., & van Gilst, W. H. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.03.028 · Cited by 46
Self-citationVasan, R. S., SULLIVAN, L. M., & Roubenoff, R. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00292-7 · Cited by 43
Self-citationBiomarker-Based Risk Prediction in the Community
AbouEzzeddine, O. F., McKie, P. M., Scott, C. G., Rodeheffer, R. J., Chen, H. H., Felker, G. M., Jaffe, A. S., Burnett, J. C. J., & Redfield, M. M. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.663 · Cited by 36
Wong, Y. W., Thomas, L. E., Sun, J., McMurray, J. J. V., Krum, H., Hernandez, A. F., Rutten, G. E. H. M., Leiter, L. A., Standl, E., Haffner, S. M., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000086 · Cited by 30
Quibrera, P. M., Shahar, E., Rosamond, W. D., Agarwal, S. K., He, M. M., Folsom, A. R., Ni, H., Chang, P. P., Ballantyne, C. M., Bertoni, A. G., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/7jnz-p412 · Cited by 18
Self-citation
Cited by
Groenewegen, A., Rutten, F. H., Mosterd, A., & Hoes, A. W. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1858 · Cited by 2,043
The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF
Savji, N., Meijers, W. C., Bartz, T. M., Bhambhani, V., Cushman, M., Nayor, M., Kizer, J. R., Sarma, A., Blaha, M. J., Gansevoort, R. T., et al. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2018.05.018 · Cited by 499
“Other 29 (1) — 2,279 (34) 248 (3) 2,556 (11)”
BackgroundSelf-citationShah, S. J., Borlaug, B. A., Kitzman, D. W., McCulloch, A. D., Blaxall, B. C., Agarwal, R., Chirinos, J. A., Collins, S., Deo, R. C., Gladwin, M. T., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.041886 · Cited by 436
Cellular and molecular pathobiology of heart failure with preserved ejection fraction
Mishra, S., & Kass, D. A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00480-6 · Cited by 417
Paulus, W. J., & Zile, M. R. (2021) · Circulation Research · doi:10.1161/circresaha.121.318159 · Cited by 393
Metadata
- Authors
- de Boer, R. A., Nayor, M., deFilippi, C. R., Enserro, D., Bhambhani, V., Kizer, J. R., Blaha, M. J., Brouwers, F. P., Cushman, M., Lima, J. A. C., Bahrami, H., van der Harst, P., Wang, T. J., Gansevoort, R. T., Fox, C. S., Gaggin, H. K., Kop, W. J., Liu, K., Vasan, R. S., Psaty, B. M., Lee, D. S., Hillege, H. L., Bartz, T. M., Benjamin, E. J., Chan, C., Allison, M., Gardin, J. M., Januzzi, J. L., Shah, S. J., Levy, D., Herrington, D. M., Larson, M. G., van Gilst, W. H., Gottdiener, J. S., Bertoni, A. G., & Ho, J. E.
- Venue
- JAMA Cardiology
- Publisher
- American Medical Association (AMA)
- Published
- 2018-03-01
- Volume
- 3
- Issue
- 3
- Pages
- 215
- ISSN
- 2380-6583 (ISSN-L)
- OpenAlex
- W2783147489
- Cited by
- 260
- References
- 45
- FWCI
- 19.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.